SCHEMBL4757155

SCHEMBL4757155

Cc1ccc(C(=O)Nc2ncc(S(C)(=O)=O)s2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.59
RAB9A P51151 9/20 0.59
KMT2A Q03164 6/20 0.59
MEN1 O00255 5/20 0.59
PKM P14618 1/20 0.59
SMN1; SMN2 Q16637 8/20 0.54
ALDH1A1 P00352 5/20 0.49
MAPT P10636 2/20 0.48
FFAR2 O15552 1/20 0.48
POLB P06746 1/20 0.48
TP53 P04637 3/20 0.47
KDM4E B2RXH2 2/20 0.47
LMNA P02545 1/20 0.47
HTT P42858 1/20 0.47
GAA P10253 2/20 0.47
CASP3 P42574 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
CCNE1 P24864 1/20 0.46
CDK2 P24941 1/20 0.46
CDK5 Q00535 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL703520 0.89 FFAR2 (0.48) NPC1RAB9AKMT2AMEN1PKM
SCHEMBL4757983 0.87 KDR (0.61) NPC1RAB9AKMT2AMEN1PKM
SCHEMBL4757157 0.84 STAT3 (0.49) NPC1RAB9AKMT2AMEN1PKM
SCHEMBL4756952 0.84 RAB9A (0.57) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL4755967 0.84 CSNK2A2 (0.47) NPC1RAB9AKMT2AMEN1PKM
SCHEMBL4757111 0.83 MEN1 (0.47) NPC1RAB9AKMT2AMEN1PKM
SCHEMBL702024 0.83 RAB9A (0.57) NPC1RAB9AKMT2AMEN1PKM
SCHEMBL4757159 0.83 MEN1 (0.57) NPC1RAB9AKMT2AMEN1PKM
SCHEMBL4757209 0.82 MEN1 (0.46) NPC1RAB9AKMT2AMEN1PKM
SCHEMBL233270 0.81 SMN1; SMN2 (0.75) NPC1RAB9AKMT2AMEN1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC NPC1 585/4885RAB9A 1694/4885KMT2A 2303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.